---
title: "Newland has obtained the approval notice for the marketing application of the raw material drug Clopidogrel Bisulfate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239067715.md"
description: "Newland has received the notice of approval for the marketing application of the raw material drug clopidogrel hydrogen sulfate from the National Medical Products Administration, marking that the drug meets the drug review standards in China. Clopidogrel hydrogen sulfate is an antiplatelet drug primarily used for the prevention and treatment of cardiovascular and cerebrovascular diseases. This approval will enrich the company's product variety"
datetime: "2025-05-07T08:20:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239067715.md)
  - [en](https://longbridge.com/en/news/239067715.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239067715.md)
---

# Newland has obtained the approval notice for the marketing application of the raw material drug Clopidogrel Bisulfate

According to the Zhitong Finance APP, Newland (301277.SZ) announced that on May 6, 2025, the company received the "Approval Notice for the Application for Market Launch of Chemical Raw Materials" for clopidogrel hydrogen sulfate raw materials issued by the National Medical Products Administration.

Clopidogrel hydrogen sulfate is a commonly used antiplatelet drug, primarily used for the prevention and treatment of cardiovascular and cerebrovascular diseases related to atherosclerotic thrombosis. Its main function is to reduce the risk of thrombosis by inhibiting platelet aggregation. The "Approval Notice for the Application for Market Launch of Chemical Raw Materials" obtained by the company indicates that this raw material meets the relevant drug review technical standards in China and has been approved for use in domestic formulations, which will further enrich the company's product variety

### Related Stocks

- [301277.CN](https://longbridge.com/en/quote/301277.CN.md)

## Related News & Research

- [IPO Winners & Losers Podcast: Cerebras, SpaceX, and the AI Takeover](https://longbridge.com/en/news/286957979.md)
- [Post Oak Energy Capital Announces Sale of UpCurve Energy Assets](https://longbridge.com/en/news/287062130.md)
- [UTG Insider Bought Shares Worth $266,556, According to a Recent SEC Filing](https://longbridge.com/en/news/287111261.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [Assessing BlueNord (OB:BNOR) Valuation After Its US$400 Million Refinancing Deal](https://longbridge.com/en/news/287098111.md)